The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.

[1]  A. Benson,et al.  Adjusted Hospital Sentinel Lymph Node Positivity Rates in Melanoma: A Novel Potential Measure of Quality , 2016, Annals of surgery.

[2]  M. Bigby,et al.  Sentinel lymph node biopsy in melanoma , 2015, BMJ : British Medical Journal.

[3]  J. Malvehy,et al.  Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma. , 2015, European journal of cancer.

[4]  A. Eggermont,et al.  Correction to Lancet Oncol 2015; 16: 522-30. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. , 2015, The Lancet. Oncology.

[5]  P. Ascierto,et al.  Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. , 2015, The Lancet. Oncology.

[6]  R. Elashoff,et al.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma. , 2014, The New England journal of medicine.

[7]  R. Scolyer,et al.  The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients. , 2014, European journal of cancer.

[8]  K. Higgins,et al.  Waiting for thyroid surgery: A study of psychological morbidity and determinants of health associated with long wait times for thyroid surgery , 2013, The Laryngoscope.

[9]  M. Kashani-Sabet,et al.  The effect of delay time between primary melanoma biopsy and sentinel lymph node dissection on sentinel node status, recurrence, and survival , 2012, Melanoma research.

[10]  D. Schadendorf,et al.  Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Donald L Weaver,et al.  Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  G. Lyman,et al.  Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline , 2012, Annals of Surgical Oncology.

[13]  I. V. D. van der Ploeg,et al.  Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Cornelis Verhoef,et al.  EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria. , 2010, European journal of cancer.

[15]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Mihm,et al.  EANM-EORTC general recommendations for sentinel node diagnostics in melanoma , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  V. Sondak,et al.  Sentinel node biopsy and standard of care for melanoma. , 2009, Journal of the American Academy of Dermatology.

[18]  A. Eggermont,et al.  Sentinel Node Tumor Burden According to the Rotterdam Criteria Is the Most Important Prognostic Factor for Survival in Melanoma Patients: A Multicenter Study in 388 Patients With Positive Sentinel Nodes , 2008, Annals of surgery.

[19]  G. van der Wal,et al.  Waiting for elective general surgery: impact on health related quality of life and psychosocial consequences , 2007, BMC public health.

[20]  P. G. Lang,et al.  Sentinel-Node Biopsy or Nodal Observation in Melanoma , 2007 .

[21]  A. Eggermont,et al.  Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  R. Elashoff,et al.  Sentinel-node biopsy or nodal observation in melanoma. , 2006, The New England journal of medicine.

[23]  P. G. Lang,et al.  Sentinel Node Biopsy for Early-Stage Melanoma: Accuracy and Morbidity in MSLT-I, an International Multicenter Trial , 2006 .

[24]  R. Elashoff,et al.  Sentinel Node Biopsy for Early-Stage Melanoma: Accuracy and Morbidity in MSLT-I, an International Multicenter Trial , 2005, Annals of surgery.

[25]  L. Jost,et al.  ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  M. Ross,et al.  Lessons learned from the Sunbelt Melanoma Trial , 2004, Journal of surgical oncology.

[27]  F. Bray,et al.  Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia , 2003, International journal of cancer.

[28]  A. Eggermont,et al.  The development of optimal pathological assessment of sentinel lymph nodes for melanoma , 2003, The Journal of pathology.

[29]  L. Jost.  ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  R. Prescott,et al.  Clinical and Laboratory Investigations The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival , 2002 .

[31]  A. Halpern,et al.  Guidelines of care for primary cutaneous melanoma. , 2001, Journal of the American Academy of Dermatology.

[32]  D L Morton,et al.  Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. , 1999, Annals of surgery.

[33]  D. Morton,et al.  Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins. , 1999, Archives of surgery.